Coronavirus Disease 2019 (COVID-19)

Please check here periodically for updated information on in-person activities. Webinars and all of our enduring activities remain open and available to you through this site.

Boston University School of Medicine

Core curriculum

Podcast series


CME information


  Create an account or log in to participate in this activity

Partners

These activities were planned in collaboration with the Council of Medical Specialty Societies (CMSS) and the Federation of State Medical Boards (FSMB).

Accreditation

Physicians

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

CNE Contact Hours: 2.25, all of which are pharmacology credit-worthy

Risk Management and Pain Management Credits

This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study and opioid education. Several states have similar requirements. Please check with your Board to determine if this activity will fulfill your state's specific requirements.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for risk management study.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for opioid education.

American Academy of Family Physicians (AAFP)

This Enduring Material activity, SCOPE of Pain: Safer/Competent Opioid Prescribing Education, has been reviewed and is acceptable for up to 2.25 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 04/01/2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification Part 2 Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.25 MOC points and patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate and de-identified data is shared with the commercial supporters.

American Board of Medical Specialties Maintenance of Certification Part 2 Credit

Through the American Board of Medical Specialties (ABMS) ongoing commitment to increase access to practice relevant Maintenance of Certification (MOC) Activities through the ABMS Continuing Certification Directory, SCOPE of Pain has met the requirements as an MOC Part II Self-Assessment and/or MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

MOC Part II Self-Assessment Activity
MOC Part II CME Activity

Note: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board's general CME requirement (only). Please refer directly to your Member Boards' MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

In order to receive credit, participants must review the activity content (six podcast episodes) and complete the post-test and evaluation. Participants who receive a grade of 70% or greater on the post-tests will receive credit. There will also be an online follow-up survey that will be distributed two months after completion of the program in order to further measure participants? changes in knowledge and behavior.

Date of Original Release: 4/20/2020
Date of Expiration: 4/19/2021

Target audience

Physicians, nurse practitioners, registered nurses, physician assistants, nurses, dentists, pharmacists, and allied health professionals whose practices manage acute and chronic pain.

Educational objectives

At the conclusion of these activities, participants will be better able to:

  1. Optimize safety when prescribing opioids for acute pain
  2. Determine when opioid analgesics are indicated for chronic pain
  3. Assess pain and prescription opioid misuse risk
  4. Educate patients about opioid risks and realistic benefits
  5. Monitor patients on opioid therapy for benefits and harms
  6. Assess and manage worrisome opioid-taking behaviors
  7. Safely taper long-term opioid therapy
  8. Identify and manage patients with an opioid use disorder

For questions about CME, please contact cme@bu.edu.

Disclosures

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Off-Label Discussion

This activity does include discussion of the off-label use of sublingual buprenorphine to treat pain. Sublingual buprenorphine has been FDA approved for addiction treatment but not pain treatment. This presentation does include discussion of the off-label use of clonidine and tizanidine to treat opioid withdrawal symptoms. Clonidine and tizanidine are not FDA approved for this use.

Faculty

Daniel P. Alford, MD, MPH, FACP
Course Director
Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support.

Marc LaRochelle, MD
Assistant Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support.

Jessica Taylor, MD
Assistant Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support.

Alexander Y. Walley, MD, MSc
Director, Addiction Medicine Fellowship Program
Associate Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support.

Kristin Wason, MSN, NP-C, CARN
NCPD Course Advisor
Clinical Educator, Massachusetts OBAT TTA
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support.

Planning Committee

Brian Jack, MD, independent AAFP reviewer
Ilana Hardesty, Senior Operations Manager, Boston University School of Medicine CME Office
Carmela Townsend, DNP, MS/MBA, RN, Lead Nurse Planner, Boston University School of Medicine CME Office
Jason Worcester, MD, independent CME reviewer
Stephen A. Wyatt, DO, independent CME reviewer

Planning Committee members have nothing to disclose with regard to commercial support.

Disclaimer

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Disclosure of support

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration.

Boston University Council of Medical Specialty Societies Federation of State Medican Boards